| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5655568 | Digestive and Liver Disease | 2017 | 6 Pages |
Abstract
This is the first experience reporting a clinical benefit and tolerability of mycophenolate mofetil in patients with inflammatory bowel disease and multiple previous failures to other immunosuppressants and/or biologics.
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
Fabio Salvatore Macaluso, Marcello Maida, Sara Renna, Emanuele Orlando, Marco Affronti, Chiara Sapienza, Mariangela Dimarco, Rosalba Orlando, Giulia Rizzuto, Mario Cottone, Ambrogio Orlando,